Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -77.44%3.87B | 290.32%17.14B | -151.80%-9.01B | 18.31%17.39B | 237.87%14.7B | -307.59%-10.66B | -36.16%5.14B | 198.33%8.04B | -46.52%2.7B | 18.19%5.04B |
Net profit before non-cash adjustment | 34.97%13.27B | 18.26%9.83B | -9.98%8.31B | 0.12%9.23B | 16.07%9.22B | 3.22%7.95B | 11.37%7.7B | 1.60%6.91B | 42.57%6.8B | 29.79%4.77B |
Total adjustment of non-cash items | -153.19%-1.07B | -861.36%-423M | -115.71%-44M | 1.45%280M | -14.55%276M | 12.15%323M | 26.87%288M | 27.53%227M | -44.03%178M | -16.32%318M |
-Depreciation and amortization | 56.03%763M | 8.91%489M | -6.85%449M | 5.01%482M | 1.55%459M | -3.83%452M | 9.81%470M | 50.70%428M | -17.68%284M | -18.82%345M |
-Reversal of impairment losses recognized in profit and loss | --102M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5M |
-Share of associates | ---146M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Disposal profit | -169.70%-1.45B | -146.79%-538M | -878.57%-218M | -54.10%28M | -45.05%61M | 511.11%111M | 43.75%-27M | -469.23%-48M | -88.07%13M | 5,350.00%109M |
-Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---73M |
-Other non-cash items | 9.36%-339M | -36.00%-374M | -19.57%-275M | 5.74%-230M | -1.67%-244M | -54.84%-240M | -1.31%-155M | -28.57%-153M | -75.00%-119M | -44.68%-68M |
Changes in working capital | -207.70%-8.33B | 144.76%7.73B | -319.39%-17.28B | 51.51%7.87B | 127.46%5.2B | -564.88%-18.93B | -413.89%-2.85B | 121.19%907M | -8,818.75%-4.28B | -123.53%-48M |
-Change in receivables | -252.06%-7.29B | 123.16%4.79B | -410.01%-20.69B | 121.47%6.68B | 133.69%3.01B | -36.75%-8.95B | -195.68%-6.54B | 159.70%6.84B | -361.00%-11.45B | 596.27%4.39B |
-Change in inventory | 73.79%-54M | -131.46%-206M | -211.25%-89M | 48.15%80M | 775.00%54M | 61.90%-8M | 77.42%-21M | -338.46%-93M | 114.39%39M | -267.28%-271M |
-Change in payables | -197.31%-1.99B | -111.97%-670M | 711.91%5.6B | -210.37%-915M | 107.34%829M | -308.33%-11.3B | 196.31%5.42B | -236.34%-5.63B | 299.52%4.13B | -7,766.67%-2.07B |
-Provision for loans, leases and other losses | -170.09%-75M | 463.16%107M | 127.94%19M | -950.00%-68M | -69.23%8M | 18.18%26M | 229.41%22M | 92.77%-17M | 59.76%-235M | -178.49%-584M |
-Changes in other current assets | -133.79%-148M | 116.37%438M | -525.28%-2.68B | 857.83%629M | -359.38%-83M | 101.10%32M | -835.19%-2.9B | 2.60%395M | 136.32%385M | -105.43%-1.06B |
-Changes in other current liabilities | -62.39%1.23B | 479.79%3.27B | -61.71%564M | 7.13%1.47B | 8.78%1.38B | 7.67%1.26B | 301.37%1.17B | -120.46%-583M | 733.33%2.85B | -167.06%-450M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -15.94%-80M | 27.37%-69M | 19.49%-95M | 5.60%-118M | -3.31%-125M | 16.55%-121M | -11.54%-145M | 9.09%-130M | 7.14%-143M | -2.67%-154M |
Interest received (cash flow from operating activities) | -7.43%411M | 19.03%444M | 6.88%373M | -5.16%349M | 1.94%368M | 17.97%361M | 6.99%306M | 8.75%286M | 16.89%263M | 13.64%225M |
Tax refund paid | -128.63%-3.6B | 47.31%-1.58B | 11.49%-2.99B | -53.64%-3.38B | 29.55%-2.2B | -57.89%-3.12B | 29.53%-1.98B | -50.59%-2.8B | 15.75%-1.86B | -84.94%-2.21B |
Other operating cash inflow (outflow) | 0.00%-1M | -1M | 0 | -1M | 0 | -1M | 0 | 0 | 27.79%-343M | -47,400.00%-475M |
Operating cash flow | -96.26%596M | 236.04%15.94B | -182.28%-11.72B | 11.76%14.24B | 194.10%12.74B | -507.86%-13.54B | -38.46%3.32B | 782.98%5.4B | -74.82%611M | -22.14%2.43B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 10.08%-1.62B | -47.91%-1.81B | -228.23%-1.22B | 51.81%-372M | -170.88%-772M | 10.38%-285M | 68.23%-318M | -289.49%-1B | 33.76%-257M | -218.03%-388M |
Net business purchase and sale | 89.90%-311M | -14,557.14%-3.08B | 93.50%-21M | -2,591.67%-323M | ---12M | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 187.13%2.12B | 29.25%738M | 405.31%571M | -48.40%113M | 1,052.63%219M | -75.32%19M | 2,025.00%77M | -144.44%-4M | 0.00%9M | 105.11%9M |
Advance cash and loans provided to other parties | --0 | --0 | -116.67%-91M | ---42M | --0 | ---1M | --0 | ---- | 0.00%-2M | 50.00%-2M |
Repayment of advance payments to other parties and cash income from loans | 11.11%10M | -77.50%9M | 3,900.00%40M | 0.00%1M | -97.78%1M | 4,400.00%45M | 0.00%1M | -66.67%1M | 50.00%3M | -50.00%2M |
Net changes in other investments | -34.63%-797M | -292.05%-592M | -58.95%-151M | -31.94%-95M | -620.00%-72M | 86.67%-10M | 82.88%-75M | -78.05%-438M | -1,018.18%-246M | -117.46%-22M |
Investing cash flow | 87.25%-603M | -441.70%-4.73B | -21.59%-873M | -12.89%-718M | -174.14%-636M | 26.35%-232M | 78.16%-315M | -192.49%-1.44B | -22.94%-493M | -133.14%-401M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -63.96%-464M | 77.86%-283M | -156.11%-1.28B | -258.92%-499M | 613.64%314M | 107.22%44M | -3,906.25%-609M | 138.10%16M | 97.42%-42M | -4,071.79%-1.63B |
Net common stock issuance | --0 | --0 | 99.89%-1M | 41.27%-915M | -155,700.00%-1.56B | 90.00%-1M | -150.00%-10M | 20.00%-4M | -25.00%-5M | 20.00%-4M |
Cash dividends paid | -22.17%-2.36B | 0.00%-1.94B | 6.61%-1.94B | -6.04%-2.07B | -43.78%-1.95B | -24.45%-1.36B | -16.67%-1.09B | -10.51%-936M | -18.79%-847M | 15.82%-713M |
Net other fund-raising expenses | ---1M | ---- | ---- | 97.62%-1M | -4,100.00%-42M | ---1M | ---- | ---1M | ---- | ---- |
Financing cash flow | -27.55%-2.83B | 30.99%-2.22B | 7.83%-3.21B | -7.62%-3.49B | -146.01%-3.24B | 23.03%-1.32B | -84.97%-1.71B | -3.47%-925M | 61.86%-894M | -162.78%-2.34B |
Net cash flow | ||||||||||
Beginning cash position | 58.06%25.35B | -49.48%16.04B | 46.87%31.75B | 69.19%21.62B | -54.14%12.78B | 4.93%27.86B | 12.80%26.55B | -3.37%23.54B | -0.98%24.36B | 9.71%24.6B |
Current changes in cash | -131.53%-2.84B | 156.91%8.99B | -257.48%-15.81B | 13.20%10.04B | 158.75%8.87B | -1,266.15%-15.09B | -57.27%1.29B | 490.21%3.03B | -144.03%-776M | -115.49%-318M |
Effect of exchange rate changes | -51.42%154M | 226.80%317M | 2.11%97M | 495.83%95M | -366.67%-24M | -40.00%9M | 207.14%15M | 68.89%-14M | -157.69%-45M | -38.10%78M |
Cash adjustments other than cash changes | ---1M | ---- | ---2M | ---- | -100.00%-2M | ---1M | ---- | 0.00%-1M | ---1M | ---- |
End cash Position | -10.58%22.67B | 58.06%25.35B | -49.48%16.04B | 46.87%31.75B | 69.19%21.62B | -54.14%12.78B | 4.93%27.86B | 12.80%26.55B | -3.37%23.54B | -0.98%24.36B |
Free cash flow | -107.29%-1.03B | 209.22%14.13B | -193.29%-12.94B | 15.87%13.87B | 186.56%11.97B | -570.66%-13.83B | -32.74%2.94B | 1,140.91%4.37B | -82.71%352M | -31.95%2.04B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |